Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2205
https://www.valueinhealthjournal.com/article/S1098-3015(16)33571-9/fulltext
Title :
Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33571-9&doi=10.1016/j.jval.2016.09.2205
First page :
A731
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2091